170503 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants Molecules with a "CD"-designation not provided for elsewhere in
SIRPa EXPRESSION ON T CELLS IS A BIOMARKER FOR FUNCTIONAL T CELLS DURING EXHAUSTION
#302COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND RELATED DISORDERS
#303Cancer Progression Risk Assessment by Microvascular Phenotype
#304Assaying Bladder-Associated Samples, Identifying and Treating Bladder-Associated Neoplasia, and Kits for Use Therein
#305SPATIAL MAPPING OF CELLS AND CELL TYPES IN COMPLEX TISSUES
#306METHODS FOR DETECTING AND QUANTIFYING MEMBRANE-ASSOCIATED PROTEINS
#307METHOD FOR DETECTING CELLS
#308COMPOSITION FOR DIAGNOSING BONE METASTASIS OF CANCER AND METHOD FOR DIAGNOSING BONE METASTASIS OF CANCER USING SAME
#309Tepoxalin targeting of ABCB1 overexpressing cancers
#310Therapeutic anti-CD9 antibody
#311BIOMARKERS
#312GLX-DERIVED MOLECULE DETECTION
#313ANTIBODY QUANTIFICATION IN BIOLOGICAL SAMPLES
#314USE OF BMMF1 REP PROTEIN AS A BIOMARKER FOR BREAST CANCER
#315METHOD FOR FORECASTING ARRIVAL OF DRUG INSIDE DISEASED TISSUE
#316COMPOSITIONS, METHODS AND KITS FOR DIAGNOSING AND TREATING CD206 EXPRESSING CELL-RELATED DISORDERS
#317Protein signatures for distinguishing between bacterial and viral infections
#318Anti-kit antibodies and uses thereof
#319CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS
#320METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER
#321Classification and Treatment of Gastric Cancer
#322FUNCTIONAL SCREEN FOR SMALL MOLECULE AND MONOCLONAL ANTIBODY DRUG SENSITIVITY IN MULTIPLE MYELOMA PATIENTS
#323Methods for producing fibroadipogenic progenitor cells
#324Targeting metastasis stem cells through a fatty acid receptor (CD36)
#325METHODS FOR THE DETECTION AND QUANTIFICATION OF CIRCULATING TUMOR CELL MIMICS
#326Antibody constructs and methods of treating cancer
#327Antibodies against signal-regulatory protein alpha and methods of use
#328Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#329CD31SHED AS A MOLECULAR TARGET FOR IMAGING OF INFLAMMATION
#330Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection
#331METHOD FOR PROVIDING INFORMATION ON THERAPEUTIC REACTION OF CANCER IMMUNOTHERAPY AND KIT USING SAME
#332CD131 binding proteins and uses thereof
#333METHODS FOR TREATING AORTIC ANEURYSM DISEASE
#334METHODS FOR MONITORING POLYMORPHONUCLEAR MYELOID DERIVED SUPPRESSOR CELLS
#335Detection of CD-155, the poliovirus receptor
#336COMPOSITIONS AND METHODS FOR CELL TRANSPLANTATION
#337Biomarker composition for predicting cancer malignant prognosis induced by microplastic exposure
#338METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#339DATA PROCESSING SYSTEM FOR IDENTIFYING A THERAPEUTIC AGENT
#340Methods for detecting and treating cancers having adenosine pathway activation
#341Methods for detecting and treating cancers having adenosine pathway activation
#342Method for preparing dual-functional hybrid thin-film for self-calibration detection of tumor-derived exosomes
#343NEAR INFRA-RED LIGHT SHEET MICROSCOPY THROUGH SCATTERING TISSUES
#344Selection of patients for combination therapy
#345METHODS FOR PROGNOSIS AND MANAGEMENT OF DISEASE
#346COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#347DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#348Methods of immunotherapy
#349Methods for Evaluating Angiogenesis
#350ANTI-TLR9 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME
#351Method for measuring cellular uptake of molecules
#352TREATMENT AND DIAGNOSIS OF ANAEMIA
#353Antibodies against CDCP1 for the treatment and detection of cancer
#354Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
#355Mouse having a humanized cluster of differentiation 47 gene
#356Compositions and methods for predicting post-surgical cardiovascular events
#357Methods for Monitoring Polymorphonuclear Myeloid Derived Suppressor Cells and Compositions and Methods of Treatment of Cancer
#358Image analysis and measurement of biological samples
#359Corneal endothelial cell marker
#360Aptamers specific for TLR-4 and uses thereof
#361SPECIFICITY ASSAY FOR NOVEL TARGET ANTIGEN BINDING MOIETIES
#362ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)
#363DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#364Anti-presepsin antibody
#365Anti-CD20 antibody and uses thereof
#366BIOMARKERS FOR RADIATION TREATMENT
#367CD47 monoclonal antibodies and uses thereof
#368INTRACELLULAR NITRIC OXIDE AS A BIOMARKER FOR INCREASED SUSCEPTIBILITY SYSTEMIC INFLAMMATION
#369JAG1 EXPRESSION PREDICTS THERAPEUTIC RESPONSE IN NASH
#370Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#371Immortalization of Splenic and Peripheral Blood Macrophages Using a Multi-Cistronic V-RAF/V-MYC Lentivirus
#372Anti-CD39 antibodies
#373Antibody molecules to LAG-3 and uses thereof
#374DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#375QUANTITATIVE BIOMARKERS OF EHV-1 SUSCEPTIBILITY AND PROTECTION
#376METHODS OF DIAGNOSING AND TREATING BLADDER CANCER
#377Methods and devices for complexing target entities
#378METHODS AND SYSTEMS FOR IDENTIFICATION AND TREATMENT OF PATHOLOGICAL NEURODEGENERATION AND AGE-RELATED COGNITIVE DECLINE
#379Reagents and Methods for Breast Cancer Detection
#380METHODS FOR DECONTAMINATING CIRCUITS FOR PRODUCING GLUCOSE POLYMERS AND HYDROLYSATES OF GLUCOSE POLYMERS
#381METHOD FOR OBTAINING A SPERMATOZOID CELL POPULATION WITH IMPROVED FITNESS
#382USE OF ANTI-CD26 ANTIBODY LEVELS AS AUTOIMMUNE AND/OR INFLAMMATORY DISEASE BIOMARKERS
#383CEACAM1 based point-of-care cancer diagnostic
#384Systems and methods for determining a chemical state
#385PVRIG polypeptides and methods of treatment
#386Novel CD47 Monoclonal Antibodies and Uses Thereof
#387METHODS OF DETECTING A POLYPEPTIDE HAVING ANAPLASTIC LYMPHOMA KINASE ACTIVITY IN KIDNEY CANCER
#388DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#389CANCERS EXPRESSING CCR5 AND METHODS OF TREATMENT OF SAME
#390Brown adipocyte progenitors in human skeletal muscle
#391ASTROCYTE EXOSOME COMPLEMENT-BASED ASSAY FOR NEUROINFLAMMATION IN ALZHEIMER'S DISEASE AND USES THEREOF
#392Antibody molecules to PD-1 and uses thereof
#393MOLECULAR PROFILING FOR CANCER
#394Quantitative cellular method for determining the biological activity of an anti-CD26 ligand
#395METHOD OF IDENTIFYING ADIPOSE STEM CELLS
#396Antibody molecules to TIM-3 and uses thereof
#397Nanosensors and methods for detection of biological markers
#398Device and procedure for producing a cellular pharmaceutical product enriched in genetically modified target cells at the bedside or in a surgical room
#399Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#400Methods and materials for assessing and treating cancer
#401BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF
#402KIT FOR IN VITRO OR EX VIVO MEASUREMENT OF THE EXPRESSION OF sCD127 IN A BIOLOGICAL SAMPLE
#403Methods for treating, preventing and predicting risk of developing breast cancer
#404Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#405Identification of subpopulations of cardiomyocytes
#406BIOMARKERS IN EX VIVO LUNG PERFUSION (EVLP) PERFUSATE
#407METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT SUFFERING OF RENAL CANCER TO SUNITINIB
#408USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
#409De novo binding domain containing polypeptides and uses thereof
#410Method of detecting TIM-3 using antibody molecules to TIM-3
#411METHODS FOR IDENTIFYING MYELOMA TUMOR-INITIATING CELLS AND TARGETED THERAPY
#412CANCER MARKERS AND METHODS OF USE THEREOF
#413MACROPINOCYTOSING HUMAN ANTI-CD46 ANTIBODIES AND TARGETED CANCER THERAPEUTICS
#414CD8 T cell subsets as a biomarker for predicting non-fusion after spinal fusion surgery
#415COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#416EXTRACELLULAR VESICLE MARKERS FOR STABLE ANGINA AND UNSTABLE ANGINA
#417System, method, and article for detecting abnormal cells using multi-dimensional analysis
#418Method for cancer prognosis
#419Detection of bioprosthetic valve degeneration
#420Preparing genetically modified cells using a device that is configured for sterile processing of cells at the bedside or in a surgical room
#421NOVEL CD47 MONOCLONAL ANTIBODIES AND USES THEREOF
#422Light chain variable regions
#423METHODS AND KITS FOR IDENTIFYING EFFECTOR TREG CELLS
#424TARGETING B CELLS TO ENHANCE RESPONSE TO IMMUNE CHECKPOINT BLOCKADE
#425Peptide Libraries and Methods of Use
#426METHODS OF CLASSIFYING DIFFUSE LARGE B-CELL LYMPHOMA
#427Methods for Diagnosing and Treating Subjects for Pulmonary Exacerbation
#428Non-Glycosylated suPar Biomarkers and Uses Thereof
#429CD8+T-cell subsets as markers for prediction of delayed fracture healing
#430DETECTION OF LEUKOCYTE-DERIVED MICROVESICLES BY FLUO-SENSITIVE FLOW CYTOMETRY
#431Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof
#432FGFR/PD-1 COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#433IMAGE ANALYSIS AND MEASUREMENT OF BIOLOGICAL SAMPLES
#434Methods for identification, assessment, prevention, and treatment of cancer using PD-L1 isoforms
#435Agents that modulate immune cell activation and methods of use thereof
#436Method for treating rheumatoid arthritis
#437Anti-CD47 monoclonal antibody and use thereof
#438KITS, METHODS AND THEIR USES FOR DETECTING CELL-CELL INTERACTIONS IN A SAMPLE KITS
#439Targeting DNA-PKCS and B7-H1 to treat cancer
#440ERYTHROPOIETIC ROLE OF RESIDENT MACROPHAGES IN HEMATOPOIETIC ORGANS
#441Toll-like receptor 9 antagonists
#442METHOD FOR THE PROGNOSIS OF SURVIVAL TIME OF A PATIENT SUFFERING FROM A SOLID CANCER
#443RESIDUAL DISEASE DETECTION IN MULTIPLE MYELOMA
#444Internalizing human monoclonal antibodies targeting prostate and other cancer cells
#445Antibodies specific to human poliovirus receptor (PVR)
#446Biomarker Panel For Diagnosing Cancer
#447Methods of Isolating Naive Regulatory T Cells
#448Methods and devices for high throughput purification
#449METHODS AND DEVICES FOR HIGH THROUGHPUT PURIFICATION
#450Anti oligosaccharide antibody
#451Compositions and methods for treating multiple myeloma
#452METHODS AND KITS FOR DETECTING BASOPHIL ACTIVATION
#453Isolation of human lung progenitors derived from pluripotent stem cells
#454FLOW CYTOMETRY ASSAY METHODS
#455Systems and methods for immunomodulation of mucosal-associated invariant T cells
#456Methods of identifying and treating patient populations amenable to cancer immunotherapy
#457Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms
#458Modulation of immunity and CEACAM1 activity
#459ANTI-PD-1 SCFVS
#460Methods for increasing palatability of pet foodstuff
#461TREATING RESPIRATORY CONDITIONS
#462METHODS OF ANALYZING PLURALITIES OF CELLS AND DETECTING PROTEIN SEQUENCE VARIANTS IN BIOLOGICAL PRODUCT MANUFACTURING
#463Anti-CD137 antibodies and uses thereof
#464Anti-CD137 antibodies and uses thereof
#465Biomarkers for lung cancer stem cells
#466STRATEGIES TO ASSESS AND/OR PRODUCE CELL POPULATIONS WITH PREDICTIVE ENGRAFTMENT POTENTIAL
#467Image analysis and measurement of biological samples
#468CANCER TREATMENT
#469METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO IMMUNOTHERAPY
#470Methods for the identification, targeting and isolation of human dendritic cell (DC) precursors “pre-DC” and their uses thereof
#471Analysis of anti-erythrocyte antibody in the presence of antibody directed against a surface-bound erythrocyte antigen
#472NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING
#473Enigma and CDH18 as companion diagnostics for CDK4 inhibitors
#474Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies
#475Use of CD24 for lowering low-density lipoprotein cholesterol levels
#476METHOD FOR TESTING NK CELL ACTIVITY USING SYNERGISTIC ACTIVITY OF RECEPTOR, AND METHOD FOR DIAGNOSING DISEASE ASSOCIATED WITH NK CELL ACTIVITY USING SAME
#477Compositions and methods relating to T peripheral helper cells in autoantibody-associated conditions
#478Method for Predicting the Response of a Subject with an Autoimmune Disease to a B Cell-Targeting Therapy
#479Method for Determining Prognosis of Cancer
#480BIOMARKERS AND TREATMENTS FOR METASTATIC CANCER
#481METHODS OF TREATEMENT OF CANCER DISEASE BY TARGETTING TUMOR ASSOCIATED MACROPHAGE
#482Cell population comprising mesenchymal stem cells derived from fetal appendage, method for producing the same, and pharmaceutical composition
#483USE OF sCD14 OR ITS FRAGMENTS OR DERIVATIVES FOR RISK STRATIFICATION, DIAGNOSIS AND PROGNOSIS
#484PROTEIN BIOMARKER PANELS FOR DETECTING COLORECTAL CANCER AND ADVANCED ADENOMA
#485ANTI-PD-L1 AND ANTI-CTLA-4 ANTIBODIES FOR TREATING NON-SMALL CELL LUNG CANCER
#486Early diagnosis of infections
#487METHOD FOR THE PROGNOSIS OF MULTIPLE MYELOMA
#488Anti-PD-L1 antibodies and variants
#489Therapeutic and diagnostic methods for cancer
#490CD37-binding molecules and immunoconjugates thereof
#491Aptamers specific for TLR-4 and uses thereof
#492Diagnostic anti-PD-L1 antibody and use thereof
#493DIAGNOSTIC METHOD FOR MULTIPLE SCLEROSIS
#494Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels
#495Methods and compositions for identifying leukemic stem cells
#496Methods for increasing palatability of pet foodstuff
#497Human otic progenitor identification and isolation
#498USE OF CD31 PEPTIDES IN THE TREATMENT OF THROMBOTIC AND AUTOIMMUNE DISORDERS
#499Methods and materials for treating renal cell carcinoma
#500Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#501System and method for capturing and analyzing cells
#502Methods and devices for high throughput purification
#503Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#504C5aR INHIBITOR REDUCTION OF URINARY sCD163
#505Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#506Anti-SIRPa antibodies and their therapeutic applications
#507Protein signatures for distinguishing between bacterial and viral infections
#508Adult stem cell compositions and methods of identification and isolation
#509Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#510Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#511Method of isolating circulating tumor cells
#512Methods of treating by administering anti-kit antibodies
#513Targeting metastasis stem cells through a fatty acid receptor (CD36)
#514NEW TOLL-LIKE RECEPTOR 9 ANTAGONISTS
#515Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#516Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#517Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#518CD31 as a molecular target for imaging of inflammation
#519TREATING PATIENTS BASED ON IMMUNE SUBTYPES
#520METHOD OF IDENTIFYING ADIPOSE STEM CELLS
#521HUMANIZED MOUSE MODEL FOR CANCER METASTASIS
#522METHOD FOR CHARACTERIZATION OF CELL SPECIFIC MICROVESICLES
#523PREECLAMPSIA BIOMARKERS AND RELATED SYSTEMS AND METHODS
#524ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS
#525Methods and compositions for the diagnosis and treatment of cancer
#526Hematopoietic cell phenotyping using circulating cell-free markers
#527ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES
#528CD131 binding proteins
#529Systemic immune activation and biomarkers of nonceliac wheat/gluten sensitivity
#530Classification and Treatment of Gastric Cancer
#531DLL3 MODULATORS AND METHODS OF USE
#532MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS
#533Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof
#534Antibody molecules to CD73 and uses thereof
#535TROPONIN I AND SOLUBLE UROKINASE RECEPTOR DETECTION FOR DETERMINING THE RISK OF CARDIOVASCULAR DISEASE
#536Therapeutic anti-CD9 antibody
#537Microfluidic device for cell separation and uses thereof
#538Method for diagnosing disseminated intravascular coagulation (DIC)
#539Diagnostic markers of immunosenescence and methods for determining the susceptibility to nosocomial infections
#540Fusion proteins comprising partial tetraspanin sequences and a system thereof for presenting peptides on the cell surface
#541Inflammatory Disease Treatment Composition Including Anti-Myosin Regulatory Light-Chain Polypeptide Antibody
#542USE OF CD36 TO IDENTIFY CANCER SUBJECTS FOR TREATMENT
#543Methods of identifying immune cells in PD-L1 positive tumor tissue
#544Methods for determining the risk of cardiovascular disease in a subject having a chronic viral infection through the measurement of lysophosphatidic acid
#545ANTIBODY WHICH SPECIFICALLY BINDS TO HUMAN CRTH2
#546Methods for detecting tissue infiltrating NK cells
#547Cytometric assays
#548BIOMARKERS FOR DETECTION OF TUBERCULOSIS RISK
#549Flow cytometry system and methods for the diagnosis of infectious disease
#550CD318 as a marker for, and CD318 inhibition as a treatment for, autoimmune disease
#551System and method for capturing and analyzing cells
#552Cancer treatment composition combining anti-CD26 antibody and other anticancer agent
#553USE OF CD146 AS A MARKER OF THE VASCULAR WALL TENSION
#554Methods of measuring potential for therapeutic potency and defining dosages for autologous cell therapies
#555Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#556Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#557Anti-CD33 antibodies and immunoconjugates
#558Materials and methods for detecting cancer based on urinary levels of RHAMM
#559Biomarkers for radiation treatment
#560ISOLATION, EXPANSION AND USE OF CLONOGENIC ENDOTHELIAL PROGENITOR CELLS
#561METHOD FOR DETERMINING CANCER
#562Method for detecting lipid bilayer membrane particles or fragments thereof
#563Systems and methods for determining a chemical state
#564DETECTION OF ACUTE MYELOID LEUKAEMIA
#565JAG1 expression predicts therapeutic response in NASH
#566DIAGNOSTIC ASSAYS FOR SUPAR-β3 INTEGRIN DRIVEN KIDNEY DISEASES
#567Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#568Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#569Reagents and Methods for Breast Cancer Detection
#570Method of diagnosis of breast cancer
#571Antibodies specific for CLL-1
#572Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
#573Glycated CD59 peptides, their preparation, and uses thereof
#574REGULATORY T CELLS AND METHODS OF IDENTIFYING, OBTAINING AND USING TO TREAT IMMUNO-BASED DISORDERS
#575De novo binding domain containing polypeptides and uses thereof
#576De novo binding domain containing polypeptides and uses thereof
#577Methods and materials for reducing suppression of immune function
#578Method of using mouse having a humanized cluster of differentiation 47 gene
#579LYMPHOID HEMOPATHY PROGNOSIS METHOD
#580Isolation of human lung progenitors derived from pluripotent stem cells
#581Antibodies and assays for detection of CD37
#582ANTIBODIES RECOGNIZING A CARBOHYDRATE CONTAINING EPITOPE ON CD-43 AND CEA EXPRESSED ON CANCER CELLS AND METHODS USING SAME
#583NEW BIOMARKER FOR OUTCOME IN AML PATIENTS
#584PD-L2 biomarkers predictive of PD-1 pathway inhibitor responses in esophagogastric cancers
#585CD127 expression inversely correlates with FoxP3 and suppressive function of CD4 Tregs
#586Methods for prognosing and preventing metastatic liver disease
#587Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related uses
#588Method for determining a concentration of epithelial cells in a blood sample or aspirate sample
#589Detection of oral microbial virulence factors
#590KITS, COMPOSITIONS AND METHODS FOR DETECTING A BIOLOGICAL CONDITION
#591Endothelial cell derived exosomes and uses thereof
#592MEl'hods and means for diagnosing spondylarthritis using autoantibody markers
#593Method for examining renal disease
#594DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#595Anti-presepsin antibody
#596PD-L1 antibodies and uses thereof
#597Endoglin Antibodies
#598Binding proteins based on di-ubiquitin muteins and methods for generation
#599BIOLOGICAL ASSAY OF PEPTIDOGLYCANS
#600CEACAM1 BASED CANCER THERAPY AND DIAGNOSIS